Alle Fälle anzeigen
ORD 63909/2024
—·EP3831282: REMOTE MONITORING OF ANALYTE MEASUREMENTS
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieVerfahrensführungsanordnungen
- Parteien
- KlägerVertreter: Anne-Charlotte le Bihan (Bird & Bird LLP); Laurent Labatte (Bird & Bird LLP); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)Beklagte
- Abbott Logistics B.V.
- Abbott Diagnostics GmbH
- Abbott France
- Abbott Oy
- Abbott Diabetes Care Inc.
- Newyu, Inc.
- Abbott B.V.
- Abbott s.r.l.
- Abbott Scandinavia Aktiebolag
- Abbott Gesellschaft m.b.H.
- Abbott Laboratories A/S
- Abbott GmbH
- Abbott Laboratories
Vertreter: Christian Dekoninck (Taylor Wessing); François Pochart (August Debouzy) - Division
- Paris LD
- Richter
- Camille Lignieres · Judge-Rapporteur
- Technology
- Healthcare Informatics
- Sprache
- —
- Erste Entscheidung
- 11. Dez. 2024
Ansprüche
Streitig1
Nichtig erklärtall
Hinweise: Paris Local Division revoked EP 3 831 282 entirely for added matter; claim 1 as granted and as amended per AR1, AR2, AR3 all failed; infringement action dismissed for lack of legal basis.
Entscheidungen
- 2024-12-11Nichtig erklärtVerletzung (Hauptsache)Generic Order
Decision on the merits from the Paris Local Division (UPC_CFI_395/2023) delivered on 11 December 2024 in DexCom's infringement action against Abbott entities concerning EP 3 831 282. The Court found the patent invalid in its entirety — neither as granted nor as amended by auxiliary requests 1, 2 or 3 — due to added subject-matter under Art. 138(1)(c) EPC. The infringement action was dismissed for lack of legal basis. DexCom was ordered to bear Abbott's costs, with the amount to be determined in separate proceedings.
Rechtsfragen:Added matter (Art. 138(1)(c) EPC)Auxiliary requests for patent amendmentAdmissibility of new grounds for revocation in rejoinder (R. 9.2 RoP)Claim interpretation (whole-content approach)Inventive step (Art. 56 EPC)
Dokumente
- 9DC31A56B02BC3E943FBD9B92216AE51_en.pdf2024-12-11EN